Akio Osa

716 total citations
17 papers, 124 citations indexed

About

Akio Osa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Akio Osa has authored 17 papers receiving a total of 124 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 3 papers in Immunology. Recurrent topics in Akio Osa's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). Akio Osa is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). Akio Osa collaborates with scholars based in Japan. Akio Osa's co-authors include Atsushi Kumanogoh, Takayuki Takimoto, Shohei Koyama, Haruhiko Hirata, Yujiro Naito, Takayuki Shiroyama, Ichiro Kawase, Tadahiro Yamadori, Motohiro Tamiya and Tomonori Hirashima and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

Akio Osa

16 papers receiving 124 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akio Osa Japan 7 57 54 26 21 19 17 124
Luigi Della Gravara Italy 8 102 1.8× 117 2.2× 25 1.0× 15 0.7× 54 2.8× 21 192
Dennis Yiannakis United Kingdom 8 38 0.7× 77 1.4× 18 0.7× 15 0.7× 49 2.6× 16 208
Jayhyun Seo United States 5 63 1.1× 152 2.8× 31 1.2× 14 0.7× 24 1.3× 7 214
Lindsay F. Petersen United States 7 26 0.5× 73 1.4× 24 0.9× 12 0.6× 46 2.4× 17 163
Patricia Iranzo Spain 7 66 1.2× 108 2.0× 30 1.2× 8 0.4× 25 1.3× 22 158
Kobby Asubonteng United States 6 20 0.4× 64 1.2× 15 0.6× 7 0.3× 37 1.9× 11 131
Ming-Yong Zhang China 4 23 0.4× 18 0.3× 13 0.5× 9 0.4× 40 2.1× 5 112
Weijie Zhou China 8 31 0.5× 33 0.6× 34 1.3× 33 1.6× 134 7.1× 18 212
David García-Illescas Spain 6 53 0.9× 71 1.3× 27 1.0× 7 0.3× 35 1.8× 15 156
Sue Cheeseman United Kingdom 7 86 1.5× 94 1.7× 5 0.2× 24 1.1× 42 2.2× 23 178

Countries citing papers authored by Akio Osa

Since Specialization
Citations

This map shows the geographic impact of Akio Osa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akio Osa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akio Osa more than expected).

Fields of papers citing papers by Akio Osa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akio Osa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akio Osa. The network helps show where Akio Osa may publish in the future.

Co-authorship network of co-authors of Akio Osa

This figure shows the co-authorship network connecting the top 25 collaborators of Akio Osa. A scholar is included among the top collaborators of Akio Osa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akio Osa. Akio Osa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Iwahori, Kota, Takuro Nii, Takahiro Kawasaki, et al.. (2023). A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19. Scientific Reports. 13(1). 13809–13809. 1 indexed citations
2.
Naito, Yujiro, et al.. (2020). Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood. Journal of Visualized Experiments. 1 indexed citations
3.
4.
Osa, Akio, Jie Meng, Yasunari Haseda, et al.. (2019). Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice. Journal of Controlled Release. 313. 106–119. 34 indexed citations
5.
Osa, Akio, Takeshi Uenami, Yujiro Naito, et al.. (2019). Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis. Thoracic Cancer. 10(11). 2183–2187. 10 indexed citations
6.
Takimoto, Takayuki, et al.. (2019). Diffuse Pulmonary Cysts in Metastatic Angiosarcoma. Internal Medicine. 59(3). 457–458. 1 indexed citations
7.
Minami, Toshiyuki, Takashi Kijima, Shohei Koyama, et al.. (2017). Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models. Biochemical and Biophysical Research Communications. 488(4). 596–602. 8 indexed citations
8.
Osa, Akio, Shigeru Koyama, Takeshi Uenami, et al.. (2017). P2.07-009 Monitoring Nivolumab Binding as a Method to Clarify the Residual Therapeutic Effects in Previously Treated Lung Cancer Patients. Journal of Thoracic Oncology. 12(11). S2418–S2419. 1 indexed citations
9.
Otsuka, Tomoyuki, Aya Tanaka, Hiroaki Azukizawa, et al.. (2016). Successful treatment with gefitinib after Stevens–Johnson syndrome associated with afatinib therapy in a patient with adenocarcinoma of the lung. International Cancer Conference Journal. 6(1). 38–41. 6 indexed citations
10.
Tamiya, Motohiro, Takayuki Shiroyama, Akio Osa, et al.. (2015). Nanoparticle Albumin-bound Paclitaxel+Carboplatin Therapy for Small Cell Lung Cancer Combined with Squamous Cell Carcinoma and Interstitial Lung Disease. Internal Medicine. 54(22). 2911–2913. 4 indexed citations
11.
Shiroyama, Takayuki, Ayako Tanaka, Motohiro Tamiya, et al.. (2015). A Rare Case of Pleomorphic Carcinoma of the Lung Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement. Internal Medicine. 54(21). 2741–2743. 3 indexed citations
12.
13.
Suzuki, Hidekazu, Tomonori Hirashima, Norio Okamoto, et al.. (2014). Relationship between progression‐free survival and overall survival in patients with advanced non‐small cell lung cancer treated with anticancer agents after first‐line treatment failure. Asia-Pacific Journal of Clinical Oncology. 11(2). 121–128. 10 indexed citations
14.
Suzuki, Hidekazu, Kazuhiro Asami, Tomonori Hirashima, et al.. (2013). Stratification of Malignant Pleural Mesothelioma Prognosis Using Recursive Partitioning Analysis. Lung. 192(1). 191–195. 10 indexed citations
15.
Takimoto, Takayuki, et al.. (2012). Tension Pneumomediastinum in a Patient with Interstitial Pneumonia. Internal Medicine. 51(1). 125–125. 1 indexed citations
16.
Tetsumoto, Satoshi, Akio Osa, Takashi Kijima, et al.. (2011). Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib. International Journal of Clinical Oncology. 17(2). 155–159. 14 indexed citations
17.
Takimoto, Takayuki, et al.. (2011). Tubular nephrotoxicity induced by docetaxel in non-small-cell lung cancer patients. International Journal of Clinical Oncology. 17(4). 395–398. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luigi Della Gravara Breakdown of academic impact, for papers by Dennis Yiannakis Breakdown of academic impact, for papers by Jayhyun Seo Breakdown of academic impact, for papers by Lindsay F. Petersen Breakdown of academic impact, for papers by Patricia Iranzo Breakdown of academic impact, for papers by Kobby Asubonteng Breakdown of academic impact, for papers by Ming-Yong Zhang Breakdown of academic impact, for papers by Weijie Zhou Breakdown of academic impact, for papers by David García-Illescas Breakdown of academic impact, for papers by Sue Cheeseman
Rankless by CCL
2026